# Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy

> **NCT06143410** · NA · UNKNOWN · sponsor: **Erasme University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Diagnostic Gastroscopy

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution
- **DRUG:** Saline administration as placebo
- **DRUG:** Propofol injection
- **PROCEDURE:** gastroscopy

## Key facts

- **NCT ID:** NCT06143410
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-08
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143410, "Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06143410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*